Morphine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
The prototypical opioid analgesic, morphine is used for the management of severe pain when non-opioid alternatives are inadequate. It is the standard against which other opioids are compared. Available in immediate- and extended-release oral formulations, IV, IM, and intrathecal preparations, morphine is essential in cancer pain management and palliative care.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
The prototypical opioid analgesic, morphine is used for the management of severe pain when non-opioid alternatives are inadequate. NutriStack rates the supporting evidence as strong. Common adult dosing is IR: 15–30 mg every 4 hours as needed; ER: 15–30 mg every 8–12 hours initially (individualized titration) (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
- Constipation (nearly universal)
- Nausea and vomiting
- Drowsiness and sedation
- Significant respiratory depression
- Acute or severe bronchial asthma in unmonitored settings7
The bottom line
Evidence rating strong. Most-documented uses: effective relief of severe pain, gold standard for cancer pain management, multiple routes of administration (oral, iv, im, intrathecal, epidural). 10 sources indexed (2019–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Acts as a full agonist at mu-opioid receptors (primary analgesic effect) and kappa-opioid receptors in the central nervous system. Mu-receptor activation in the periaqueductal gray, rostral ventromedial medulla, and dorsal horn of the spinal cord inhibits ascending pain transmission and activates descending inhibitory pathways. Also produces sedation, euphoria, respiratory depression, and reduced GI motility.8,10
Dosing & protocol.
Oral bioavailability is 20–40% due to extensive first-pass hepatic metabolism; ER formulations must be swallowed whole
Full safety detail.
Side effects
- Constipation (nearly universal)
- Nausea and vomiting
- Drowsiness and sedation
- Respiratory depression
- Pruritus
- Urinary retention
- Hypotension
- Physical dependence, tolerance, and addiction
Contraindications
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
7- 1The analgesic effects of novel fascial plane blocks compared with intrathecal morphine after Caesarean delivery: a systematic review and meta-analysisPMIDHussain N, Brull R, Thaete L et al. · British journal of anaesthesia · 2025
Hussain N, Brull R, Thaete L et al.. The analgesic effects of novel fascial plane blocks compared with intrathecal morphine after Caesarean delivery: a systematic review and meta-analysis. British journal of anaesthesia. 2025
- 2Intrathecal Morphine for Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPMIDCiconini LE, Ramos WA, Fonseca ACL et al. · Annals of cardiac anaesthesia · 2024
Ciconini LE, Ramos WA, Fonseca ACL et al.. Intrathecal Morphine for Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Annals of cardiac anaesthesia. 2024
- 3Effectiveness and Safety of Hydromorphone Compared to Morphine for Postoperative Analgesia: A Systematic Review and Meta-analysisPMIDLi Y, Yue X, Liang S et al. · Pain physician · 2024
Li Y, Yue X, Liang S et al.. Effectiveness and Safety of Hydromorphone Compared to Morphine for Postoperative Analgesia: A Systematic Review and Meta-analysis. Pain physician. 2024
- 4Non-pulmonary complications of intrathecal morphine administration: a systematic review and meta-analysis with meta-regressionPMIDRenard Y, El-Boghdadly K, Rossel JB et al. · British journal of anaesthesia · 2024
Renard Y, El-Boghdadly K, Rossel JB et al.. Non-pulmonary complications of intrathecal morphine administration: a systematic review and meta-analysis with meta-regression. British journal of anaesthesia. 2024
- 5Intrathecal Morphine and Post-Operative Pain Relief in Robotic Surgeries: A Systematic Review and Meta-AnalysisPMIDTee ZH, Tsoi EHC, Lee Q et al. · Journal of clinical medicine · 2023
Tee ZH, Tsoi EHC, Lee Q et al.. Intrathecal Morphine and Post-Operative Pain Relief in Robotic Surgeries: A Systematic Review and Meta-Analysis. Journal of clinical medicine. 2023
- 6Morphine or hydromorphone: which should be preferred? A systematic reviewPMIDSpénard S, Gélinas C, D Trottier E et al. · Archives of disease in childhood · 2021
Spénard S, Gélinas C, D Trottier E et al.. Morphine or hydromorphone: which should be preferred? A systematic review. Archives of disease in childhood. 2021
- 7Morphine in acute coronary syndrome: systematic review and meta-analysisPMIDDuarte GS, Nunes-Ferreira A, Rodrigues FB et al. · BMJ open · 2019
Duarte GS, Nunes-Ferreira A, Rodrigues FB et al.. Morphine in acute coronary syndrome: systematic review and meta-analysis. BMJ open. 2019
Reference material
3- 8Dowell D et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022. MMWR. 2022.Source linkedPMID
- 9Wiffen PJ et al. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2016.Source linkedPMID
- 10Pasternak GW. Molecular biology of opioid analgesia. J Pain Symptom Manage. 2005.Source linkedPMID
Common questions.
Quick answers about Morphine, drawn from the data on this page.
What is Morphine?
The prototypical opioid analgesic, morphine is used for the management of severe pain when non-opioid alternatives are inadequate. It is the standard against which other opioids are compared. Available in immediate- and extended-release oral formulations, IV, IM, and intrathecal preparations, morphine is essential in cancer pain management and palliative care.
What is Morphine used for?
Commonly cited benefits of Morphine include: Effective relief of severe pain; Gold standard for cancer pain management; Multiple routes of administration (oral, IV, IM, intrathecal, epidural); Extended-release formulations for around-the-clock pain control. NutriStack rates the overall evidence as strong.
What is a typical dose of Morphine?
A typical adult dose of Morphine is IR: 15–30 mg every 4 hours as needed; ER: 15–30 mg every 8–12 hours initially (individualized titration) (as prescribed by your physician). The commonly recommended form is Immediate-release tablet/solution or extended-release tablet/capsule. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Morphine?
Reported side effects include constipation (nearly universal), nausea and vomiting, drowsiness and sedation, respiratory depression, pruritus, urinary retention. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Morphine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Morphine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.